title: Development of neonatal respiratory and intensive care: Chinese perspectives.
abstract: Recent economic improvements in China have allowed the development of perinatal-neonatal care in sub-provincial regions. However, variations in neonatal respiratory and intensive care exist, especially in regions with limited resources. We conducted a series of collaborative clinical investigations into neonatal hypoxemic respiratory failure (NRF). In the study period from 2004 to 2005, this nationwide study found an incidence of NRF of 13.4% of total admissions to neonatal intensive care units (NICUs), with a mortality of 32%. Fewer than 30% of infants with respiratory distress syndrome (RDS) received surfactant treatment. Most cases of NRF had birth weights (BWs) of 1,000-1,500 g. Approximately 60% of deaths were due to withdrawal of respiratory support because of economic restraints despite initial response to therapy. Extremely low BW or gestational age accounted for less than 2% of all NRF cases, and their survival rate was less than 50%. A prospective clinical epidemiologic study of NRF in 14 NICUs, mainly sub-provincial centers, in Hebei province was undertaken in the study period from 2007 to 2008. NRF made up 16.9% of total NICU admissions, with increased use of surfactant (>50%) and continuous positive airway pressure (>80%) in this study. However, mortality due to RDS, meconium aspiration syndrome and pulmonary infection/sepsis remained higher than 30%, in part affected by socioeconomic factors. With measures to assist hospitalized neonates from low income families in urban areas, as well as the 'new rural cooperative health care program' to subsidize families from rural areas, the quality and affordability of NICU services may be improved in the forthcoming years.
authors.affiliation: Department of Neonatology, Children's Hospital of Fudan University, Shanghai, China. bsun@shmu.edu.cn
authors.forename: Bo
authors.initials: B
authors.lastname: Sun
authors.forename: Li
authors.initials: L
authors.lastname: Ma
authors.forename: Xiaohong
authors.initials: X
authors.lastname: Liu
authors.forename: Xirong
authors.initials: X
authors.lastname: Gao
authors.forename: Liming
authors.initials: L
authors.lastname: Ni
mesh_terms: D002681:China / Q000453:epidemiology; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature; D007363:Intensive Care Units, Neonatal / Q000191:economics / Q000706:statistics & numerical data; D015931:Intensive Care, Neonatal / Q000191:economics / Q000458:organization & administration / Q000706:statistics & numerical data*; D008297:Male; D011663:Pulmonary Surfactants / Q000627:therapeutic use; D012127:Respiratory Distress Syndrome, Newborn / Q000188:drug therapy / Q000453:epidemiology; D012131:Respiratory Insufficiency / Q000188:drug therapy / Q000453:epidemiology; D012138:Respiratory Therapy / Q000191:economics / Q000706:statistics & numerical data*; D015996:Survival Rate
chemical_list: D011663:Pulmonary Surfactants